Arthritis drug that helps Covid ICU patients has wider benefits, trial finds

Researchers say tocilizumab could also help patients on general wards and relieve pressure on NHSCoronavirus – latest updatesSee all our coronavirus coverageA rheumatoid arthritis drug previously found to save lives among intensive care patients with Covid could also help those receiving oxygen on general wards and reduce pressure on the NHS, researchers have found.A trial calledRemap-Cap revealed last month that the anti-inflammatory drugtocilizumab cut both the risk of death among Covid patients in intensive care and the length of time patients spent in such units.Continue reading...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: Coronavirus Medical research UK news World news Source Type: news